These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15347253)

  • 1. FIBROSpect II: a potential noninvasive test to assess hepatic fibrosis.
    Poordad FF
    Expert Rev Mol Diagn; 2004 Sep; 4(5):593-7. PubMed ID: 15347253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
    Islam S; Antonsson L; Westin J; Lagging M
    Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G; Vario A; Guido M; Alberti A
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy?
    Mardini H; Record C
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):441-7. PubMed ID: 16259794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transient elastography for diagnosing liver cirrhosis].
    Erhardt A; Lörke J; Vogt C; Poremba C; Willers R; Sagir A; Häussinger D
    Dtsch Med Wochenschr; 2006 Dec; 131(49):2765-9. PubMed ID: 17136655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and quantitation of fibrosis.
    Manning DS; Afdhal NH
    Gastroenterology; 2008 May; 134(6):1670-81. PubMed ID: 18471546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to measure liver fibrosis in viral hepatitis?].
    Pariente A
    Rev Prat; 2005 Mar; 55(6):646-9. PubMed ID: 15913116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic fibrosis: physiopathology and biological diagnosis].
    Housset C; Guéchot J
    Pathol Biol (Paris); 1999 Nov; 47(9):886-94. PubMed ID: 10609268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.